Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns

European Heart Journal: Acute Cardiovascular Care

Volumn 5, Issue 1, 2016, Pages 3-12

  Bueno, Héctor ^a   Sinnaeve, Peter ^b   Annemans, Lieven ^c   Danchin, Nicolas ^d   Licour, Muriel ^e   Medina, Jesús ^e   Pocock, Stuart ^f   Sánchez Covisa, Joaquín ^e   Storey, Robert F ^g   Jukema, J Wouter ^h   Zeymer, Uwe ⁱ   De Werf, Frans Van ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c VUB   (Belgium)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e ASTRAZENECA   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g UNIVERSITY OF SHEFFIELD   (United Kingdom)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ Institut fur Herzinfarktforschung Ludwigshafen   (Germany)

Author keywords

Acute coronary syndromes; Anti coagulants; Anti platelet drugs; Real world

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; EPTIFIBATIDE; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; RECOMBINANT PLASMINOGEN ACTIVATOR; STREPTOKINASE; TENECTEPLASE; TICLOPIDINE; TIROFIBAN; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; ELECTROCARDIOGRAPHY; FIBRINOLYSIS; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPERFUSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; ANTAGONISTS AND INHIBITORS; COHORT ANALYSIS; FEMALE; LONG TERM CARE; MALE; MIDDLE AGED; TOTAL QUALITY MANAGEMENT;

ACUTE CORONARY SYNDROME; AGED; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT;

EID: 84993804200     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872614565912     Document Type: Article

References (18)

1. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
2. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2012;126:875-910.
3. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-e425.
4. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
5. Bueno H, Danchin N, Tafalla M, et al. EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics. Am Heart J 2013;165:8-14.
6. Pocock S, Bueno H, Licour M, et al. Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study. Eur Heart J Acute Cardiovasc Care 2014; Epub ahead of print 9 October 2014 pii: 2048872614554198.
7. Sinnaeve PR, Zeymer U, Bueno H, et al. Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: Findings from the EPICOR study. Eur Heart J Acute Cardiovasc Care 2014;Sept 10, pii: 2048872614551544 [Epub ahead of print].
8. Elbarouni B, Elmanfud O, Yan RT, et al. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Am Heart J 2010;160:420-427.
9. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006;355:2308-2320.
10. Brunetti ND, Di Pietro G, Aquilino A, et al. Pre-hospital electrocardiogram triage with tele-cardiology support is associated with shorter time-to-balloon and higher rates of timely reperfusion even in rural areas: data from the Bari-Barletta/ Andria/Trani public emergency medical service 118 registry on primary angioplasty in ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care 2014;3(3):204-213.
11. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-2619.
12. Bellemain-Appaix A, O'Connor SA, Silvain J, et al. Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. JAMA 2012;308:2507-2516.
13. Montalescot G, Bolognese L, Dudek D, et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med 2013;369:999-1010.
14. Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177-1189.
15. Fox KA, Goodman SG, Anderson FA, Jr., et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24:1414-1424.
16. Budaj A, Brieger D, Steg PG, et al. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2003;146:999-1006.
17. Roe MT, White JA, Kaul P, et al. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial. Circ Cardiovasc Qual Outcomes 2012;5:205-213.
18. Zeymer U, James S, Berkenboom G, et al. Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI. Eur J Prev Cardiol 2013;20:218-228.